RDY:NYSE
Dr Reddy's Laboratories Ltd
12,78 US$
arrow_upward
+0,12%(+0,015) 1D
14. okt., 13.50.17 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for RDY...
Åbn
12,70 US$
Høj
12,94 US$
Lav
12,65 US$
Markedsværdi
10,80 mia.
Gns. vol.
3,17 mio.
Volumen
1,98 mio.
Udbytte
0,65 %
Kvartalsvis udbytte
0,02 US$
Ex-dato
10. jul. 2026
P/E-forhold
30,66
Højeste i 52 uger
15,67 US$
Laveste i 52 uger
11,36 US$
Indtægt pr. aktie
0,42 US$
Beta
0,30
Aktier i omløb
834,64 mio.
Antal ansatte
28 t
Åbn
12,70 US$
Høj
12,94 US$
Lav
12,65 US$
Markedsværdi
10,80 mia.
Gns. vol.
3,17 mio.
Volumen
1,98 mio.
Udbytte
0,65 %
Kvartalsvis udbytte
0,02 US$
Ex-dato
10. jul. 2026
P/E-forhold
30,66
Højeste i 52 uger
15,67 US$
Laveste i 52 uger
11,36 US$
Indtægt pr. aktie
0,42 US$
Beta
0,30
Aktier i omløb
834,64 mio.
Antal ansatte
28 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
TipRanks
·
for 49 minutter siden
Dr. Reddy’s Receives USFDA Form 483 After Pre-Approval Inspection at Visakhapatnam Plant
Stock Titan
·
for 1 time siden
An FDA pre-approval inspection ends with observations at Dr. Reddy’s (RDY) Visakhapatnam plant.
ad-hoc-news.de
·
for 7 timer siden
Dr Reddy stock trades at INR 1,211.20 before October 23 results
Stock Traders Daily
·
for 20 timer siden
Liquidity Mapping Around (RDY) Price Events
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Om Dr Reddy's Laboratories Ltd
Administrerende direktørErez Israeli
Ansatte27,5 t
Grundlagt1984
HovedsædeHyderabad, Andhra Pradesh, Indien
Sektor-
Websitedrreddys.com